Insider Trading History of Zdraveski Zoran

The following table details the insider trading activities (stock purchases, stock sales, and stock option exercises) of Zdraveski Zoran since 2019. This trader's CIK number is 1741285. At the time of last reporting, Zdraveski Zoran was the See Remarks of Tscan Therapeutics, Inc.. (stock ticker symbol TCRX). Also see all insider trading activities at Tscan Therapeutics, Inc..

Note that in the past ZDRAVESKI ZORAN also reported insider trading activities as an insider of the following companies:

Yearly summary of insider trading at Tscan Therapeutics, Inc. (TCRX) by Zdraveski Zoran

Insider Buying Insider Sales Option Exercises
Year Symbol Shares Value Shares Value Shares Value
2024 TCRX 0 $0 164,686 $952,049 157,186 $488,062
2021 TCRX 4,716 $35,256 0 $0 0 $0

Yearly summary of insider trading at Dianthus Therapeutics, Inc. /de/ (MGTA) by Zdraveski Zoran

Insider Buying Insider Sales Option Exercises
Year Symbol Shares Value Shares Value Shares Value
2019 MGTA 0 $0 12,083 $193,453 0 $0


Insider trading activities at 2 companies by Zdraveski Zoran:

1. Tscan Therapeutics, Inc. (TCRX)

2. Dianthus Therapeutics, Inc. /de/ (MGTA)

Table 1. Insider trading of Tscan Therapeutics, Inc. (TCRX) by Zdraveski Zoran

Trade Date Symbol Trade Type Shares Price ($) Value ($)
2024-08-23 TCRX Sale 164,686 5.78 952,049
2024-08-23 TCRX Option Ex 157,186 3.10 488,062
2021-09-23 TCRX Buy 4,716 7.48 35,256

Table 2. Insider trading of Dianthus Therapeutics, Inc. /de/ (MGTA) by Zdraveski Zoran

Trade Date Symbol Trade Type Shares Price ($) Value ($)
2019-12-23 MGTA Sale 4,181 16.03 67,021
2019-12-24 MGTA Sale 7,902 16.00 126,432

Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Zdraveski Zoran (See Remarks of Tscan Therapeutics, Inc. at the time of this reporting) see the Securities and Exchange Commission (SEC) website.



©2023, insider-monitor.com. All rights reserved.